DE69919179D1 - Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen - Google Patents
Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungenInfo
- Publication number
- DE69919179D1 DE69919179D1 DE69919179T DE69919179T DE69919179D1 DE 69919179 D1 DE69919179 D1 DE 69919179D1 DE 69919179 T DE69919179 T DE 69919179T DE 69919179 T DE69919179 T DE 69919179T DE 69919179 D1 DE69919179 D1 DE 69919179D1
- Authority
- DE
- Germany
- Prior art keywords
- analogs
- phenyl
- delta
- lactone
- substituted gamma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 150000003951 lactams Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9963798P | 1998-09-09 | 1998-09-09 | |
US99637P | 1998-09-09 | ||
US12150799P | 1999-02-23 | 1999-02-23 | |
US121507P | 1999-02-23 | ||
US14951799P | 1999-08-17 | 1999-08-17 | |
US149517P | 1999-08-17 | ||
PCT/CA1999/000819 WO2000014083A1 (en) | 1998-09-09 | 1999-09-09 | SUBSTITUTED η-PHENYL-Δ-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69919179D1 true DE69919179D1 (de) | 2004-09-09 |
DE69919179T2 DE69919179T2 (de) | 2005-07-28 |
Family
ID=27378872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69919179T Expired - Lifetime DE69919179T2 (de) | 1998-09-09 | 1999-09-09 | Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen |
Country Status (9)
Country | Link |
---|---|
US (1) | US6458829B1 (de) |
EP (1) | EP1112262B1 (de) |
JP (1) | JP4979157B2 (de) |
AT (1) | ATE272628T1 (de) |
AU (1) | AU757052B2 (de) |
CA (1) | CA2343732C (de) |
DE (1) | DE69919179T2 (de) |
ES (1) | ES2226422T3 (de) |
WO (1) | WO2000014083A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6770658B2 (en) * | 1998-09-09 | 2004-08-03 | Inflazyme Pharmaceuticals Ltd. | Substituted γ-phenyl-Δ-lactams and uses related thereto |
US9931318B2 (en) * | 2003-04-08 | 2018-04-03 | Dart Neuroscience (Cayman) Ltd. | Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
US20040224316A1 (en) | 2000-08-10 | 2004-11-11 | Tully Timothy P. | Augmented cognitive training |
US7868015B2 (en) | 2000-08-10 | 2011-01-11 | Cold Spring Harbor Laboratory | Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
US8153646B2 (en) * | 2000-08-10 | 2012-04-10 | Dart Neuroscience (Cayman) Ltd. | Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
KR100439425B1 (ko) * | 2001-03-22 | 2004-07-05 | (주)바이오케어 | 잔토리졸을 포함하는 조성물 및 그 용도 |
WO2002094320A1 (fr) * | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | Compositions therapeutiques permettant de reparer la chondropathie |
US7041280B2 (en) | 2001-06-29 | 2006-05-09 | Genzyme Corporation | Aryl boronate functionalized polymers for treating obesity |
US6858592B2 (en) | 2001-06-29 | 2005-02-22 | Genzyme Corporation | Aryl boronic acids for treating obesity |
US7642252B2 (en) * | 2002-07-22 | 2010-01-05 | Chemgenex Pharmaceuticals, Inc. | Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
EP2177626B1 (de) | 2002-08-19 | 2013-12-18 | Dart NeuroScience (Cayman) Ltd | Abtastverfahren für kognitive Verstärker |
ES2213485B1 (es) * | 2003-02-13 | 2005-12-16 | Almirall Prodesfarma, S.A. | Derivados de la 2-fenilpiran-4-ona. |
WO2005095965A1 (en) * | 2004-03-03 | 2005-10-13 | Bayer Technology Services Gmbh | Analytical platform and method for generating protein expression profiles of cell populations |
US20060193893A1 (en) * | 2005-02-10 | 2006-08-31 | Chemgenex Pharmaceuticals, Inc. | Medical devices |
CA2600822A1 (en) * | 2005-03-14 | 2006-09-21 | Nycomed Gmbh | Method for preventing cardiovascular diseases |
BRPI0711816A2 (pt) | 2006-05-19 | 2011-12-13 | Helicon Therapeutics Inc | inibidores fosfodiesterase 4 para rehabilitação motora e cognitiva |
GB0722769D0 (en) * | 2007-11-21 | 2008-01-02 | Biolipox Ab | New compounds |
JP2010521444A (ja) * | 2007-03-12 | 2010-06-24 | バイオリポックス エービー | 炎症の治療において有用なピペリジノン類 |
CA2684219C (en) * | 2007-04-13 | 2017-05-23 | Chemgenex Pharmaceuticals, Inc. | Oral cephalotaxine dosage forms |
AU2008326381B2 (en) * | 2007-11-21 | 2014-10-23 | Decode Genetics Ehf | Biaryl PDE4 inhibitors for treating inflammation |
EP2674417A3 (de) * | 2007-11-21 | 2014-04-09 | Decode Genetics EHF | Biaryl-PDE4-Inhibitoren zur Behandlung von Entzündungen |
WO2011114103A1 (en) | 2010-03-18 | 2011-09-22 | Biolipox Ab | Pyrimidinones for use as medicaments |
US8883857B2 (en) | 2012-12-07 | 2014-11-11 | Baylor College Of Medicine | Small molecule xanthine oxidase inhibitors and methods of use |
US20150050626A1 (en) * | 2013-03-15 | 2015-02-19 | Dart Neuroscience, Llc | Systems, Methods, and Software for Improving Cognitive and Motor Abilities |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3607885A (en) * | 1968-08-15 | 1971-09-21 | Universal Oil Prod Co | Preparation of lactones such as substituted delta valerolactones |
US3644426A (en) * | 1969-08-15 | 1972-02-22 | Universal Oil Prod Co | Preparation of delta valero-lactones |
US3814771A (en) * | 1970-11-19 | 1974-06-04 | T Shen | 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones |
US3718743A (en) * | 1970-11-19 | 1973-02-27 | Merck & Co Inc | 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones in compositions and methods for treating pain, fever and inflammation |
JPS51131870A (en) * | 1975-01-20 | 1976-11-16 | Yoshitomi Pharmaceut Ind Ltd | A process for preparing novel amide compounds |
JPS52156859A (en) * | 1976-06-18 | 1977-12-27 | Yoshitomi Pharmaceut Ind Ltd | Heterocyclic amide derivatives |
US4616089A (en) * | 1983-08-03 | 1986-10-07 | University Of California | Synthetic anti-inflammatory derivatives of manoalide |
JP3101053B2 (ja) * | 1992-02-07 | 2000-10-23 | 株式会社共立 | 新規化合物及び該化合物を含有するマツノザイセンチュウ殺線虫剤 |
DE19603477A1 (de) * | 1996-01-31 | 1997-08-07 | Klaus Dr Med Reuter | Tumormittel |
JP4432123B2 (ja) * | 1997-01-22 | 2010-03-17 | チッソ株式会社 | 液晶性化合物、およびこれを含む液晶組成物、およびこれを用いた液晶表示素子 |
-
1999
- 1999-09-09 AU AU55009/99A patent/AU757052B2/en not_active Ceased
- 1999-09-09 AT AT99941351T patent/ATE272628T1/de active
- 1999-09-09 EP EP99941351A patent/EP1112262B1/de not_active Expired - Lifetime
- 1999-09-09 CA CA002343732A patent/CA2343732C/en not_active Expired - Fee Related
- 1999-09-09 WO PCT/CA1999/000819 patent/WO2000014083A1/en active IP Right Grant
- 1999-09-09 JP JP2000568841A patent/JP4979157B2/ja not_active Expired - Fee Related
- 1999-09-09 DE DE69919179T patent/DE69919179T2/de not_active Expired - Lifetime
- 1999-09-09 ES ES99941351T patent/ES2226422T3/es not_active Expired - Lifetime
- 1999-09-09 US US09/786,949 patent/US6458829B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU757052B2 (en) | 2003-01-30 |
ATE272628T1 (de) | 2004-08-15 |
WO2000014083A1 (en) | 2000-03-16 |
CA2343732C (en) | 2009-06-16 |
US6458829B1 (en) | 2002-10-01 |
AU5500999A (en) | 2000-03-27 |
ES2226422T3 (es) | 2005-03-16 |
EP1112262A1 (de) | 2001-07-04 |
CA2343732A1 (en) | 2000-03-16 |
EP1112262B1 (de) | 2004-08-04 |
JP4979157B2 (ja) | 2012-07-18 |
DE69919179T2 (de) | 2005-07-28 |
JP2002524456A (ja) | 2002-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69919179D1 (de) | Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen | |
ATE163042T1 (de) | Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung | |
EE200000468A (et) | Ühendid, nende kasutamine ja farmatseutiline kompositsioon | |
EE03741B1 (et) | N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine | |
BR0112160A (pt) | Agentes antiinflamatórios seletivos para glicocorticóides | |
ATE231872T1 (de) | Thiazolopyrimidinderivate | |
DE69904804T2 (de) | Glucocorticoid selektive entzündungshemmende mittel | |
PT902789E (pt) | Derivados de androsteno | |
CY1114133T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ | |
HUP0102766A3 (en) | Aminomethylcarboxylic acid derivatives, their pharmaceutical use and pharmaceutical compositions comprising them | |
ATE218581T1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
BR0008228A (pt) | Composições de n-benzoil estaurosporinaespontaneamente dispersìveis | |
DE69528710D1 (de) | 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung | |
EE200000226A (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
DE4493718T1 (de) | Abbaubare Succinsäurederivatchelanten, Verwendungen und Zusammensetzungen davon | |
DE69706146D1 (de) | Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ITRM920305A1 (it) | Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico. | |
ATE232738T1 (de) | Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung | |
DZ3204A1 (fr) | Dérives de streptogramines, leur préparation et l es compositions qui les contiennent. | |
ATE254108T1 (de) | Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine und ihre verwendung als arzneimittel | |
SE9902673D0 (sv) | New composition | |
PE61999A1 (es) | Compuestos de tetrahidropiridina | |
IT1306143B1 (it) | Composizione per la prevenzione ed il trattamento delle alterazionimentali e comportamentali. | |
IT1280387B1 (it) | Uso di 2, 3-diidro-4(1h)-chinazolinoni e di composizioni farmaceutiche che li contengono nel trattamento dei disturbi | |
FI972988A0 (fi) | Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: BIOLIPOX AB, SOLNA, SE |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: REHBERG HUEPPE + PARTNER, 37073 GOETTINGEN |
|
R082 | Change of representative |
Ref document number: 1112262 Country of ref document: EP Representative=s name: REHBERG HUEPPE + PARTNER, 37073 GOETTINGEN, DE |